Korrektur
Corrigendum to ‘The Ninth Edition Staging Project Publications’ [Journal of Thoracic Oncology (2022-2024)]
Journal of Thoracic Oncology · 2026-08 · 21 (8) · 103455
DOI: 10.1016/j.jtho.2025.08.020 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of Thoracic Oncology, 2026-08. Gefördert von: AstraZeneca, Boehringer Ingelheim.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- AstraZeneca
- Boehringer Ingelheim
Zitieren
APA
(2026). Corrigendum to ‘The Ninth Edition Staging Project Publications’ [Journal of Thoracic Oncology (2022-2024)]. Journal of Thoracic Oncology, 21(8), 103455. https://doi.org/10.1016/j.jtho.2025.08.020
Vancouver
Corrigendum to ‘The Ninth Edition Staging Project Publications’ [Journal of Thoracic Oncology (2022-2024)]. Journal of Thoracic Oncology. 2026;21(8):103455. doi:10.1016/j.jtho.2025.08.020
BibTeX
@article{euvimed2026,
title = {Corrigendum to ‘The Ninth Edition Staging Project Publications’ [Journal of Thoracic Oncology (2022-2024)]},
journal = {Journal of Thoracic Oncology},
year = {2026},
volume = {21},
number = {8},
pages = {103455},
doi = {10.1016/j.jtho.2025.08.020}
}
EUVIMED